Calamos Advisors LLC Sells 16,145 Shares of Colgate-Palmolive Company $CL

Calamos Advisors LLC decreased its position in Colgate-Palmolive Company (NYSE:CL) by 5.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 289,808 shares of the company’s stock after selling 16,145 shares during the quarter. Calamos Advisors LLC’s holdings in Colgate-Palmolive were worth $22,901,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CL. Pacer Advisors Inc. raised its holdings in Colgate-Palmolive by 3,052.2% in the third quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company’s stock worth $215,602,000 after purchasing an additional 2,611,485 shares in the last quarter. Diamond Hill Capital Management Inc. raised its holdings in Colgate-Palmolive by 46.7% in the third quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock worth $645,719,000 after purchasing an additional 2,572,796 shares in the last quarter. Amundi raised its holdings in Colgate-Palmolive by 41.6% in the third quarter. Amundi now owns 6,294,445 shares of the company’s stock worth $487,505,000 after purchasing an additional 1,850,412 shares in the last quarter. Two Sigma Investments LP raised its holdings in Colgate-Palmolive by 360.9% in the third quarter. Two Sigma Investments LP now owns 2,126,249 shares of the company’s stock worth $169,972,000 after purchasing an additional 1,664,949 shares in the last quarter. Finally, SG Americas Securities LLC raised its holdings in Colgate-Palmolive by 3,896.0% in the fourth quarter. SG Americas Securities LLC now owns 1,189,005 shares of the company’s stock worth $93,955,000 after purchasing an additional 1,159,250 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

CL has been the topic of several analyst reports. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $97.00 to $95.00 and set an “overweight” rating on the stock in a report on Friday, April 17th. Jefferies Financial Group boosted their target price on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Citigroup boosted their target price on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, February 2nd. Royal Bank Of Canada set a $102.00 target price on Colgate-Palmolive in a report on Thursday, April 9th. Finally, Bank of America dropped their target price on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a report on Friday, April 10th. Twelve equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $95.56.

Colgate-Palmolive Stock Performance

Shares of CL opened at $84.65 on Friday. The business’s fifty day simple moving average is $88.79 and its two-hundred day simple moving average is $83.87. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The company has a market cap of $67.92 billion, a price-to-earnings ratio of 32.31, a P/E/G ratio of 4.28 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.91 earnings per share. Research analysts anticipate that Colgate-Palmolive Company will post 3.85 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, April 20th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive’s dividend payout ratio is currently 80.92%.

Insiders Place Their Bets

In other news, COO Panagiotis Tsourapas sold 35,000 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the transaction, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $985,363.15. This represents a 77.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares in the company, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 184,683 shares of company stock valued at $17,486,693. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.